What is the Ending Marijuana Prohibition Act?
March 22nd, 2019
The Ending Federal Marijuana Prohibition Act of 2019 was filed by Reps. Don Young (R-AK) and Tulsi Gabbard (D-HI) on Thursday, March 7, 2019. Created to catapult cannabis into the mainstream market, the bill boasts a total of 39 co-sponsors, the names of whom you can view here.
In addition to normalizing cannabis consumption and regulating it in the same way as tobacco and alcohol, the Ending Federal Marijuana Prohibition Act of 2019 eliminates marijuana and the plant’s psychoactive constituent THC (tetrahydrocannabinol) from Schedule 1.
Amending the Controlled Substances Act in such a way means that cannabis consumers do not run the risk of being faced with civil or criminal penalties. Not only this, but the bill abolishes criminal penalties for anyone caught exporting, importing, manufacturing, distributing and/or possessing marijuana with intent to supply.
“Our archaic marijuana policies — based on stigma and outdated myths — have been used to wage a failed War on Drugs. Families have been torn apart, communities left fractured, and over-criminalization and mass incarceration have become the norm,” Gabbard said during a press conference. “In 2017 alone, our country arrested 600,000 people just for possession of marijuana. Our bipartisan legislation takes a step toward ending the failed war on drugs, ending the federal prohibition on marijuana, and ensuring that our policies are guided by facts and the truth.”
Something that should be noted is that the Ending Federal Marijuana Prohibition Act of 2019 criminalizes cannabis shipments and transports to states that have not yet legalized pot sales and possession. Anyone who violates the law will be faced with a maximum of one year behind bars, a fine, or both. Regardless, the Act would finally legalize the green leafy plant nationwide.
The Ending Federal Marijuana Prohibition Act of 2019 Would Deschedule the Plant
Consumer and patient access to cannabis is simplified thanks to the Ending Federal Marijuana Prohibition Act of 2019. This law will effectively act as a catalyst for research and innovation, whilst removing the barricade that previously hindered criminal justice reform, cannabis research, and innovation.
“For too long, the federal government has stood in the way of states that have acted to set their own marijuana policy, and it is long past time Congress modernized these outdated laws,” Congressman Don Young told reporters. He went on to say how proud he was to introduce two pieces of bipartisan legislation with Congresswoman Tulsi Gabbard. “I look forward to working with Congresswoman Gabbard and my friends on both sides of the aisle to see these initiatives become law.”
“The Ending Federal Prohibition Act is about acknowledging political, scientific, and economic reality. Marijuana legalization is here to stay and it is time that federal policy reflect that.” said NORML Executive Director Erik Altieri. “This legislation is effective in its simplicity, it will deschedule marijuana from the Controlled Substances Act and end federal prohibition once and for all, full stop.”
What’s more, cannabis could provide relief and hope for individuals who endure a medical ailment/condition caused by their jobs, such as veterans and football players. Descheduling cannabis under the Ending Federal Marijuana Prohibition Act of 2019 means that there is less demand for opioid prescriptions, what with cannabis being a safer and non-addictive alternative.
More than 100,000 veterans have lost their lives as a result of opioid overdose or suicide within the last 15 years, according to the Founder & CEO of Veterans Cannabis Coalition, Eric Goepel. Millions of servicemen have been prescribed addictive and often dangerous painkillers to ease problems like pain, post traumatic stress disorder (PTSD), anxiety, insomnia, nightmares and depression.
“If it helps veterans, it can help all Americans, said Goepel, adding that, “the time is long past due to end this 80 year injustice and dismantle prohibition.”
What Is the Marijuana Data Collection Act?
Aside from the Ending Federal Prohibition Act, both lawmakers introduced a separate bill titled the Marijuana Data Collection Act. This law would “allow us the opportunity to make sure we are governed by the truth and facts and not misinformation and lies,” Gabbard said.
Statewide legalization issues would be overseen under this measure, which would intensely analyze the aftermath of state legalized medicinal and non-medicinal cannabis programs from different perspectives. Examples of the issues that would be studied include public health, criminal justice, state revenues, employment, opioid use, and substance abuse.
The End of Federal Cannabis Prohibition
Since the Democratic-House flip that occurred late last year, there has been plenty of hype surrounding the topic of federal cannabis prohibition, with many activists hopeful that cannabis reform might occur in 2019. Now that the U.S. House of Representatives is dominated by Democrats, measures for reform should gain the required votes to pass.
While the House is on-board with the Ending Federal Prohibition Act and the Marijuana Data Collection Act, the Senate is not exactly supportive of the bills. Senate Majority Leader Mitch McConnell could be the biggest roadblock, since the anti-pot politician is disapproving of nationwide legalization.
On the other hand, an increasing number of U.S. residents are warming up to the idea of legal weed. Just last year, national polling data accumulated by the Center for American Progress revealed how 68 percent of registered voters “support the legalization of marijuana.” This data indicates the highest level of support for cannabis legalization ever to be reported in a scientific nationwide poll.
Although the data is promising, it doesn’t mean that 2019 will be the year that the federal government gets on-board with cannabis reform. Not if McConnell has anything to do with it, anyway. At the beginning of March, McConnell halted a measure that would expand voting rights simply because, in his own words, “I get to decide what we vote on.”
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.